Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

G Patrick Lepore

Affiliations

  • Director at Matinas Biopharma Holdings Inc. (MTNB), 2019-11-19
  • Director at Lannett Co Inc (LCI), 2019-09-05
  • Director at Pharmerica Corp (PMC), 2017-12-08
  • Director at Innoviva Inc. (INVA), 2017-04-24
  • Executive Chairman at Par Pharmaceutical Companies Inc. (PRX), 2012-10-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MTNB $1.06 100,000 Director 300,000 2019-11-15 Filing
LCI $9.82 25,000 Director 201,340 2019-09-03 Filing
MTNB $0.72 100,000 Director 200,000 2019-08-16 Filing
MTNB $0.95 100,000 Director 100,000 2019-05-16 Filing
LCI $7.32 25,000 Director 142,895 2019-05-08 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRX $34.44 2,331 Officer, Director 263,570 2011-05-09 Filing
PRX $34.43 45 Officer, Director 265,901 2011-05-09 Filing
PRX $34.42 6,309 Officer, Director 265,946 2011-05-09 Filing
PRX $34.35 200 Officer, Director 272,255 2011-05-09 Filing
PRX $34.30 400 Officer, Director 272,455 2011-05-09 Filing